Skip main navigation
Close Drawer MenuOpen Drawer Menu

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
cover

American Journal of Psychiatry

Volume 180, Issue 5

May 2023
Download PDFs:
Submit an articleSubscribeGet Free Publication Alerts
Export CitationsAdd to FavoritesRecommend
Editor’s Note
May 2023
Treatment Issues Related to the Use of Psychedelics, Trichotillomania, Social Anxiety Disorder, Schizophrenia, and Opioid Use Disorder
  • Pages:321–324
  • Published Online:1 May 2023

https://doi.org/10.1176/appi.ajp.20230209

Editorials
May 2023
Cautious Optimism for a New Treatment Option for Body-Focused Repetitive Behavior Disorders
  • Pages:325–327
  • Published Online:1 May 2023

https://doi.org/10.1176/appi.ajp.20230226

May 2023
The Attention Bias Modification Approach to Anxiety: Origins, Limitations, and Opportunities
  • Pages:328–330
  • Published Online:1 May 2023

https://doi.org/10.1176/appi.ajp.20230210

May 2023
Treating Pathologies of the Will
  • Pages:331–333
  • Published Online:1 May 2023

https://doi.org/10.1176/appi.ajp.20230182

May 2023
An Argument for Antipsychotic Polypharmacy
  • Pages:334–336
  • Published Online:1 May 2023

https://doi.org/10.1176/appi.ajp.20230180

May 2023
Drug Overdose Prevention: An Exercise in Optimism
  • Pages:337–339
  • Published Online:1 May 2023

https://doi.org/10.1176/appi.ajp.20230170

Review and Overview
May 2023
Psychedelics as Transformative Therapeutics
  • Pages:340–347
  • Published Online:1 May 2023

https://doi.org/10.1176/appi.ajp.20230172

Preview Abstract
Articles
CME
May 2023
Double-Blind Placebo-Controlled Study of Memantine in Trichotillomania and Skin-Picking Disorder
  • Pages:348–356
  • Published Online:22 February 2023

https://doi.org/10.1176/appi.ajp.20220737

Preview Abstract
CMEAudio
May 2023
Attention Bias Modification Treatment Versus a Selective Serotonin Reuptake Inhibitor Or Waiting List Control for Social Anxiety Disorder: A Randomized Clinical Trial
  • Pages:357–366
  • Published Online:22 March 2023

https://doi.org/10.1176/appi.ajp.20220533

Preview Abstract
CME
May 2023
A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT
  • Pages:367–376
  • Published Online:9 March 2023

https://doi.org/10.1176/appi.ajp.20220243

Preview Abstract
Video
May 2023
Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia
  • Pages:377–385
  • Published Online:22 March 2023

https://doi.org/10.1176/appi.ajp.20220446

Preview Abstract
Video
May 2023
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder
  • Pages:386–394
  • Published Online:9 March 2023

https://doi.org/10.1176/appi.ajp.20220312

Preview Abstract
Letter to the Editor
May 2023
Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects
  • Pages:395–396
  • Published Online:22 March 2023

https://doi.org/10.1176/appi.ajp.20220835

Issue Highlights
Featured in AJP Audio.